ARCH Venture Fund VII, L.P., 10% Owner at Syros Pharmaceuticals, Inc. (SYRS), sold 289,186 shares at $7.37 ($2.3M) on 2019-03-12, disclosed to the SEC on 2019-03-14.
Open-market sale of $2.3M SYRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.37 | 40,092 | $295K | 13.1% |
| 2 | $7.37 | 40,092 | $295K | 13.1% |
| 3 | $7.89 | 81,591 | $644K | 28.6% |
| 4 | $7.89 | 81,591 | $644K | 28.6% |
| 5 | $8.20 | 2,820 | $23K | 1.0% |
| 6 | $8.15 | 43,000 |
| $350K |
| 15.6% |
| Total | $7.79 avg | 289,186 | $2.3M | 100% |